Diminished transient outward currents in rat hypertrophied ventricular myocytes

Circulation Research
F TomitaS Kimura

Abstract

Action potential duration is prolonged in ventricular hypertrophy induced by sustained pressure overload. Since the transient outward current (I(to)) is a major factor for determining action potential duration in rat ventricular cells, we used patch-clamp techniques to compare the characteristics of I(to) in normal and hypertrophied left ventricular cells of the rat. Left ventricular pressure overload was induced by partial ligation of the abdominal aorta for 4 to 6 weeks before study. Age-matched normal rats served as controls. Pressure overload increased the heart weight-to-body weight ratio by 47.7%. I(to) was significantly smaller in hypertrophied cells than in normal cells (20.0 +/- 1.3 versus 31.0 +/- 2.1 pA/pF, respectively, at a test potential of +60 mV; P < .001). There were no differences in the steady-state inactivation, the inactivation time course, and the time course of recovery from inactivation between normal and hypertrophied cells. At the single-channel level, there were no differences in the unitary current amplitude of the single I(to) channel between normal and hypertrophied cells, and the slope conductance was 13.7 picosiemens in normal cells and 13.4 picosiemens in hypertrophied cells. The maximum open-st...Continue Reading

References

May 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R E ten EickH H Rasmussen
Feb 1, 1990·Pflügers Archiv : European journal of physiology·N TohseM Kanno
Nov 1, 1988·The Journal of Physiology·R B ClarkY Imaizumi
Apr 1, 1989·The American Journal of Physiology·S KimuraR J Myerburg
May 1, 1989·The American Journal of Physiology·R B Kleiman, S R Houser
Apr 1, 1989·Circulation Research·G N Tseng, B F Hoffman
Dec 1, 1989·The American Journal of Physiology·E F ShibataW Giles
Jul 1, 1989·Journal of Molecular and Cellular Cardiology·C NordinR S Aronson
Nov 1, 1988·The Journal of Physiology·W R Giles, Y Imaizumi
Dec 1, 1985·Circulation Research·J K Gwathmey, J P Morgan
Feb 1, 1988·Journal of Molecular and Cellular Cardiology·T KohyaA L Bassett
Jan 1, 1987·The American Journal of Physiology·D EscandeE Coraboeuf
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Feb 1, 1984·Circulation Research·I R JosephsonA M Brown
Aug 1, 1993·Cardiovascular Drugs and Therapy·R E Ten EickA L Bassett

❮ Previous
Next ❯

Citations

Aug 29, 1996·The American Journal of Cardiology·P A Boyden
Feb 28, 2003·Journal of Molecular and Cellular Cardiology·Ursula Ravens, Dobromir Dobrev
Mar 28, 2002·Pharmacology & Therapeutics·A A ArmoundasG F Tomaselli
Nov 5, 1999·Clinical and Experimental Pharmacology & Physiology·D Z DaiC H Wu
Aug 1, 1997·Journal of Cardiovascular Electrophysiology·L C FreemanR F Gilmour
Aug 1, 1997·Journal of Cardiovascular Electrophysiology·R J Myerburg, A L Basset
Oct 24, 1998·Journal of Cardiovascular Electrophysiology·A M GillisW M Lester
Mar 10, 2000·Journal of Cardiovascular Electrophysiology·J SchreieckC Schmitt
Sep 2, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Leyla Y TeosGeorges E Haddad
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·Stefan WagnerLars S Maier
Sep 2, 1999·Journal of Molecular and Cellular Cardiology·M L MartínezC Delgado
Feb 28, 2003·Expert Opinion on Investigational Drugs·Jan Nemec, Win-Kuang Shen
Dec 22, 1999·The Journal of Physiology·W GuoJ M Nerbonne
May 14, 2010·Journal of Molecular and Cellular Cardiology·Emiliano MedeiJosé Hamilton Matheus Nascimento
Aug 30, 2008·Journal of Molecular and Cellular Cardiology·Alexander Peter SchwoererHeimo Ehmke
Jan 7, 2010·Journal of Molecular and Cellular Cardiology·Hongwei JinDjamel Lebeche
Jun 15, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·M Obadah Al Chekakie
Jan 27, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mihály RuppertGábor Szabó
Jul 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Jingdong LiAnatoli N Lopatin
Apr 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Taku YamamotoHiroaki Matsubara
Dec 30, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Katy RivardCéline Fiset
Jun 15, 1999·Journal of Cardiovascular Pharmacology·V FassbenderH Nawrath
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·M BoutjdirN El-Sherif
Nov 14, 1998·The American Journal of Physiology·L M Pacioretty, R F Gilmour
Oct 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·Y G WangR W Joyner
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·George J Rozanski, Zhi Xu
Sep 24, 1998·The American Journal of Physiology·S J RialsP R Kowey
Dec 21, 2000·American Journal of Physiology. Heart and Circulatory Physiology·D StilliE Musso
Jul 17, 1999·The American Journal of Physiology·H M HimmelU Ravens
Oct 3, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Frederick M ZasadnyMatthew W Kay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.